Virginie Berger

464 total citations
22 papers, 210 citations indexed

About

Virginie Berger is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Virginie Berger has authored 22 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Virginie Berger's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and Neutropenia and Cancer Infections (4 papers). Virginie Berger is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and Neutropenia and Cancer Infections (4 papers). Virginie Berger collaborates with scholars based in France, United Kingdom and Luxembourg. Virginie Berger's co-authors include J.M. Young, José‐Antonio Arias‐Montaño, Marc G. Reyes, Sudhansu Chokroverty, M E Bruetman, M. Boisdron‐Celle, Érick Gamelin, Alain Morel, Olivier Capitain and Jean Philippe Metges and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Virginie Berger

19 papers receiving 202 citations

Peers

Countries citing papers authored by Virginie Berger

Since Specialization

Citations

This map shows the geographic impact of Virginie Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Berger more than expected).

Fields of papers citing papers by Virginie Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Berger. The network helps show where Virginie Berger may publish in the future.

Co-authorship network of co-authors of Virginie Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Berger. A scholar is included among the top collaborators of Virginie Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Berger. Virginie Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sexual dysfunction in women with breast cancer: the role of patient education 2025 ·The Journal of Sexual Medicine ·(unknown), Virginie Berger, (unknown), João Freitas, Anne Patsouris, (unknown), (unknown)	0
2	Patient satisfaction with therapeutic education in oncology: Antecedents, consequences, and the moderating effect of perceived value 2023 ·Health Services Management Research ·Blandine Labbé-Pinlon, Cindy Lombart, Virginie Berger, Didier Louis	0
3	A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification 2017 ·Seminars in Oncology ·M. Boisdron‐Celle, Jean Philippe Metges, Olivier Capitain, Antoine Adenis, Jean‐Luc Raoul, Thierry Lecomte, (unknown), Roger Faroux, Claude Masliah, A Poirier, Virginie Berger, Alain Morel, Érick Gamelin	12
4	Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach 2017 ·Seminars in Oncology ·M. Boisdron‐Celle, Olivier Capitain, Roger Faroux, Christophe Borg, Jean Philippe Metges, Marie Pierre Galais, Mehdi Kaassis, Jaafar Bennouna, Karine Bouhier‐Leporrier, Éric François, Isabelle Baumgaertner, Véronique Guerin‐Meyer, Oana Cojocarasu, C. Roemer-Bécuwe, (unknown), (unknown), (unknown), Virginie Berger, Alain Morel, Érick Gamelin	57
5	De Daft Punk à Stromae, la French Music est-elle planétaire ? 2016 ·Virginie Berger	1
6	Abstract P3-13-08: Modification of the response to chemotherapy of HER2 negative metastatic breast cancer by lipids of marine origin: A controlled, randomized, double blind dietary supplementation trial 2015 ·Cancer Research ·Philippe Bougnoux, Jacques Bonneterre, (unknown), P Soulié, H. Simon, Franck Priou, (unknown), Christelle Lévy, Caroline Goupille, Virginie Berger	1
7	Assessing 2-month clinical prognosis in patients with solid tumors: Final results of PRONOPALL study. 2014 ·Journal of Clinical Oncology ·Hugues Bourgeois, Philippe Solal‐Céligny, Olivier Capitain, Emmanuelle Bourbouloux, (unknown), M. Marcq, Éveline Boucher, Valérie Delecroix, Emmanuel Blot, (unknown), Joëlle Egreteau, Xavier Artignan, Stéphane Corbinais, (unknown), Oana Cojocarasu, Anne‐Claire Hardy‐Bessard, (unknown), Virginie Berger, Pierre Ingrand, (unknown)	1
8	Oral chemotherapy or targeted therapy compliance: An observational multicenter French study in cancer patients. 2014 ·Journal of Clinical Oncology ·(unknown), Sophie Abadie‐Lacourtoisie, P Soulié, P. Maillart, (unknown), Olivier Capitain, (unknown), Hugues Bourgeois, Jean Philippe Metges, Anne-Lise Septans, Jessy Delaye, Virginie Berger, R. Delva	2
9	Prevention of 5-FU-induced health-threatening toxicity by pretherapeutic DPD deficiency screening: Medical and economic assessment of a multiparametric approach. 2013 ·Journal of Clinical Oncology ·M. Boisdron‐Celle, Olivier Capitain, Jean‐Philippe Metges, Roger Faroux, Christophe Borg, Marie‐Pierre Galais, Mehdi Kaassis, Jaafar Bennouna, (unknown), Éric François, Isabelle Baumgaertner, Véronique Guerin‐Meyer, Oana Cojocarasu, C. Roemer-Bécuwe, (unknown), (unknown), Thierry Lecomte, Virginie Berger, Alain Morel, Érick Gamelin	6
10	Prevention of 5-FU-induced toxicities using pretherapeutic DPD deficiency screening: Medical and economic assessment of a multiparametric approach. 2013 ·Journal of Clinical Oncology ·M. Boisdron‐Celle, Olivier Capitain, Roger Faroux, Christophe Borg, Jean‐Philippe Metges, Marie‐Pierre Galais, Mehdi Kaassis, Jaafar Bennouna, (unknown), Éric François, Isabelle Baumgaertner, Véronique Guerin‐Meyer, Oana Cojocarasu, C. Roemer-Bécuwe, (unknown), (unknown), Thierry Lecomte, Virginie Berger, Alain Morel, Érick Gamelin	2
11	Health-related quality of life in cancer patients at the end of life, translation, validation, and longitudinal analysis of specific tools: study protocol for a randomized controlled trial 2012 ·Trials ·(unknown), Fabrice Kwiatkowski, (unknown), (unknown), Virginie Berger, Mariette Mercier, Franck Bonnetain	3
12	Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer 2011 ·BMC Cancer ·P. Cellier, Bernard Leduc, (unknown), Brigitte Vié, C. Chevelle, V. Vendrely, (unknown), C. Carrié, G. Calais, Pascal Burtin, L. Campion, M. Boisdron‐Celle, Alain Morel, Virginie Berger, Érick Gamelin	12
13	Assessing 2-month clinical prognosis in patients with solid tumors: First results of PRONOPALL study. 2011 ·Journal of Clinical Oncology ·Hugues Bourgeois, S Traoré, Philippe Solal‐Céligny, Olivier Dupuis, P. Maillart, Olivier Capitain, R. Delva, P Soulié, M. Marcq, Éveline Boucher, G. Ganem, Emmanuelle Bourbouloux, (unknown), Mehdi Kaassis, (unknown), (unknown), Virginie Berger, (unknown), Pierre Ingrand, (unknown)	1
14	A multicenter phase II trial of weekly paclitaxel (wPC) and epirubicin (E) in first line metastatic breast cancer (MBC) and pronostic impact of VEGF level. 2009 ·Cancer Research ·(unknown), Olivier Capitain, R. Delva, P. Maillart, Priscilla Soulié, Emmanuelle Bourbouloux, Christelle Lévy, T. Delozier, Mario Campone, (unknown), Valérie Delecroix, Jonathan Ollivier, F Casson, A Poirier, Virginie Berger, P. Fumoleau, Érick Gamelin	1
15	Preoperative radiation with concurrent daily tegafur-uracil plus leucovorin for locally advanced rectal cancer: Results of a phase II multicenter prospective study 2008 ·Journal of Clinical Oncology ·(unknown), Bernard Leduc, L. Martin, Brigitte Vié, V. Vendrely, C. Carrié, Pascal Burtin, L. Campion, Virginie Berger, C. Chevelle	2
16	Les plans de l'enquête dans la seconde moitié du XIX e siècle 2004 ·Sociétés & Représentations ·Virginie Berger	0
17	Characterisation of α1B-adrenoceptors linked to inositol phosphate formation and calcium mobilisation in human astrocytoma U373 MG cells 1999 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·José‐Antonio Arias‐Montaño, Virginie Berger, (unknown), J.M. Young	7
18	Calcium‐dependence of histamine‐ and carbachol‐induced inositol phosphate formation in human U373 MG astrocytoma cells: comparison with HeLa cells and brain slices 1994 ·British Journal of Pharmacology ·José‐Antonio Arias‐Montaño, Virginie Berger, J.M. Young	31
19	Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide. 1991 ·Journal of Pharmacology and Experimental Therapeutics ·Alain Berson, Claude Wolf, Virginie Berger, Daniel Fau, C. Chachaty, Bernard Fromenty, Dominique Pessayre	31
20	Progressive dialytic encephalopathy 1976 ·Journal of Neurology Neurosurgery & Psychiatry ·Sudhansu Chokroverty, M E Bruetman, Virginie Berger, Marc G. Reyes	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact